sglt2 inhibitors vs glp-1 agonists receptor and inhibitors: a couple at last? Blood pressure effects of SGLT2

4AH), except for a significant decrease in basal glucose levels in GLP1/GIP-treated mice (Fig

In the past month, President Trump has announced several prescription drug pricing deals between his administration and different drugmakers, including deals with Pfizer and AstraZeneca related to what they charge state Medicaid programs for some of their drugs, and a subsequent deal with a maker of in vitro fertilization (IVF) drugs aimed at lowering the cost of these treatments

Its about creating resilience from the inside out

16 , 17 Given this, the weight loss and metabolic improvements associated with GLP-1RA therapy may provide tangible benefits for this population

doi: 10.1002/jcp.25033

That is clearly unacceptable and major pressure is needed to get all companies making this class of drugs to test and validate durable and safe exit strategies